FGFR4-CovX-Body

N/A

Report date: 2025/03/20 20:00:06

Base Information

Drug NameFGFR4-CovX-Body

Drug Alias NameN/A

ClassificationBiologics > Protein drugs > Recombinant protein > Fusion proteinBiologics > Protein drugs > Immunoglobulin > Antibody > Antibody conjugate > Monoclonal antibody conjugateBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Monoclonal antibody conjugate

Mechanisms of ActionFibroblast growth factor receptor 4 modulators

TargetsFibroblast growth factor receptor 4

Therapy Area/IndicationsSolid tumours

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusDiscontinued (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesCovx Pharmaceuticals

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesCovx Pharmaceuticals

Active IndicationsN/A

Inactive IndicationsSolid tumours

Other Information

ATC CodeN/A